🇺🇸 FDA
Patent

US 11730741

6-chromanol derivatives for use as a medicament

granted A61KA61K31/353A61K31/4025

Quick answer

US patent 11730741 (6-chromanol derivatives for use as a medicament) held by Sulfateq B.V. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sulfateq B.V.
Grant date
Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/353, A61K31/4025, A61K31/496, A61K31/5377